지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2015.1
- 수록면
- 641 - 643 (3page)
이용수
초록· 키워드
오류제보하기
등록된 정보가 없습니다.
목차
등록된 정보가 없습니다.
참고문헌 (5)
참고문헌 신청
Brouard M / 2001 / Cutaneous reactions to STI571 / N Engl J Med 345 : 618 ~ 619
Hsiao LT / 2002 / Stevens-Johnson syndrome after treatment with STI571: a case report / Br J Haematol 117 : 620 ~ 622
Park HJ / 2005 / Immunohistochemical characterization of cutaneous drug eruptions by STI571 / J Dermatol Sci 38 : 9 ~ 15
Valeyrie L / 2003 / Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients / J Am Acad Dermatol 48
이재형 / 2013 / Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment / Annals of Dermatology 25 (4) : 500 ~ 502
Hsiao LT / 2002 / Stevens-Johnson syndrome after treatment with STI571: a case report / Br J Haematol 117 : 620 ~ 622
Park HJ / 2005 / Immunohistochemical characterization of cutaneous drug eruptions by STI571 / J Dermatol Sci 38 : 9 ~ 15
Valeyrie L / 2003 / Adverse cutaneous reactions to imatinib (STI571) in Philadelphia chromosome-positive leukemias: a prospective study of 54 patients / J Am Acad Dermatol 48
이재형 / 2013 / Lichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment / Annals of Dermatology 25 (4) : 500 ~ 502
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
영남의대학술지
2019 .01
-
Exacerbation of Psoriasis after Imatinib Mesylate Treatment
Annals of Dermatology
2016 .01
-
Imatinib-induced hepatitis treated by corticosteroids in a patient with metastatic gastrointestinal stromal tumor
Journal of Yeungnam Medical Science
2019 .01
-
전이성 위장관 기질종양의 수술 후 완치
Korean Journal of Helicobacter Upper Gastrointestinal Research
2018 .01
-
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) study
Blood Research
2020 .01
-
Use of imatinib mesylate in a dog with meningoencephalitis of unknown etiology
Journal of Biomedical and Translational Research
2020 .01
-
A rare case of osteonecrosis of the jaw related to imatinib
대한구강악안면외과학회지
2017 .01
-
Adjuvant Imatinib Treatment for 5 Years versus 3 Years in Patients with Ruptured Localized Gastrointestinal Stromal Tumor: A Retrospective Analysis
Cancer Research and Treatment
2022 .10
-
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications
Cancer Research and Treatment
2016 .01
-
Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib
Maxillofacial Plastic Reconstructive Surgery
2017 .12
-
Bupropion-Induced Erythema Multiforme
Annals of Dermatology
2015 .01
-
Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules
Annals of Dermatology
2021 .01
-
Effect of imatinib mesylate and rapamycin on the preformed intimal hyperplasia in rat carotid injury model
Annals of Surgical Treatment and Research
2015 .02
-
부신으로 전이된 위장관기질종양 1예
대한내과학회지
2017 .01
-
An outpatient case study of Cyaplex F: mitigated adverse effects associated with Imatinib
셀메드
2023 .09
-
Imatinib and GNF-5 Exhibit an Inhibitory Effect on Growth of Hepatocellar Carcinoma Cells by Downregulating S-phase Kinase-associated Protein 2
대한암예방학회지
2020 .01
-
Imatinib Mesylate Versus Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic Myelogenous Leukemia
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Whole-Genome and Transcriptome Sequencing Identified NOTCH2 and HES1 as Potential Markers of Response to Imatinib in Desmoid Tumor (Aggressive Fibromatosis): A Phase II Trial Study
Cancer Research and Treatment
2022 .10
-
A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
Cancer Research and Treatment
2016 .01
-
Imatinib inhibits oral squamous cell carcinoma by suppressing the PI3K/AKT/mTOR signaling pathway
한국실험동물학회 학술발표대회 논문집
2025 .02
이 논문의 저자 정보
최근 본 자료
댓글(0)
0